U.S. markets open in 4 hours 54 minutes
  • S&P Futures

    4,173.00
    -3.25 (-0.08%)
     
  • Dow Futures

    34,035.00
    -46.00 (-0.13%)
     
  • Nasdaq Futures

    14,026.25
    -3.25 (-0.02%)
     
  • Russell 2000 Futures

    2,250.90
    -8.10 (-0.36%)
     
  • Crude Oil

    63.15
    +0.02 (+0.03%)
     
  • Gold

    1,787.20
    +7.00 (+0.39%)
     
  • Silver

    26.16
    +0.05 (+0.19%)
     
  • EUR/USD

    1.2031
    +0.0050 (+0.42%)
     
  • 10-Yr Bond

    1.5730
    0.0000 (0.00%)
     
  • Vix

    17.03
    +0.46 (+2.78%)
     
  • GBP/USD

    1.3888
    +0.0049 (+0.35%)
     
  • USD/JPY

    108.1000
    -0.6830 (-0.63%)
     
  • BTC-USD

    57,068.20
    -692.60 (-1.20%)
     
  • CMC Crypto 200

    1,305.11
    -86.60 (-6.22%)
     
  • FTSE 100

    7,030.07
    +10.54 (+0.15%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

Vir Biotech, GSK to halt enrollment in COVID-19 antibody trial

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

March 3 (Reuters) - Vir Biotechnology Inc and GlaxoSmithKline plc said on Wednesday they are pausing enrollment in a part of a late-stage trial testing their COVID-19 antibody therapy on the recommendation of an independent safety monitoring panel.

(Reporting by Amruta Khandekar; Editing by Vinay Dwivedi)